MYASTHENIA GRAVIS

This study tests a new robotic surgical system (da Vinci SP) for removing part or all of a lung or the thymus gland. It involves 32 adults with early-stage lung cancer, benign lung disease, or thymoma. The goal is to see if the robot can perform these surgeries safely and effecti…

This study tests a strong chemotherapy combination followed by a stem cell transplant in people with autoimmune neurologic diseases like multiple sclerosis or stiff person syndrome that haven't responded to standard treatments. The goal is to weaken the overactive immune system s…

This study tests a drug called inebilizumab in 238 adults with myasthenia gravis, a condition that causes muscle weakness. The goal is to see if it improves daily activities and muscle function compared to a placebo. Participants receive the drug or placebo for 26 weeks, with an …

This study tests an investigational drug called efgartigimod given through a vein for adults with generalized myasthenia gravis (gMG) who do not have the usual acetylcholine receptor antibody. The goal is to see if it improves daily activities and muscle strength compared to a pl…

This study follows about 1,200 people with myasthenia gravis (MG) in China to understand how the disease is treated and how patients feel over time. Researchers will collect information on symptoms, daily activities, quality of life, and treatments every 6 months until 2027. The …

This study aims to create a simple test to determine the risk of falling for people with neuromuscular disorders like muscular dystrophy, ALS, and myasthenia gravis. Researchers will evaluate how well a series of physical tasks (like standing up, walking, and balancing) can predi…

This study is a registry that will follow about 1,500 adults with myasthenia gravis, a chronic nerve-muscle disease, to see how well their treatments work and what side effects occur. Participants receive no experimental drugs; instead, researchers collect data during regular doc…